Xueliang Fu
Shanghai, 200127, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
OSBPL10 Drives Lipophagy-Mediated Lipid Mobilization to Promote Pancreatic Ductal Adenocarcinoma Progression.
Journal: International journal of biological sciences
Published: September 20, 2025
Oncogenic GALNT5 confers FOLFIRINOX resistance via activating the MYH9/ NOTCH/ DDR axis in pancreatic ductal adenocarcinoma.
Journal: Cell death & disease
Published: October 16, 2023
Increased SPON1 promotes pancreatic ductal adenocarcinoma progression by enhancing IL-6 trans-signalling.
Journal: Cell proliferation
Published: January 23, 2022
SULF2 enhances GDF15-SMAD axis to facilitate the initiation and progression of pancreatic cancer.
Journal: Cancer letters
Published: November 15, 2021
Integrated genomic and transcriptomic analysis reveals unique characteristics of hepatic metastases and pro-metastatic role of complement C1q in pancreatic ductal adenocarcinoma.
Journal: Genome biology
Published: May 30, 2020
Molecular markers associated with perineural invasion in pancreatic ductal adenocarcinoma.
Journal: Oncology letters
Published: October 08, 2019
Transcription factor NFAT5 contributes to the glycolytic phenotype rewiring and pancreatic cancer progression via transcription of PGK1.
Journal: Cell death & disease
Published: April 03, 2019
DKK2 Impairs Tumor Immunity Infiltration and Correlates with Poor Prognosis in Pancreatic Ductal Adenocarcinoma.
Journal: Journal of immunology research
Published: February 01, 2019
High expression of DDR1 is associated with the poor prognosis in Chinese patients with pancreatic ductal adenocarcinoma.
Journal: Journal of experimental & clinical cancer research : CR
Published: May 18, 2015
Showing 1-11 of 11
Last Updated: 09/26/2026